|
|
||||||||
1 Department of Biology, Kyung Hee University, Seoul 130-701, Korea
2 Bio Lab, Samsung Advanced Institute of Technology, San14 Nongseo-ri, Giheung-eup Yongin-si, Kyoungki-do, Korea
3 Department of Pathology, Medical Center for Cancer Molecular Therapy, College of Medicine, Dong-A University, Busan, Korea
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Many nucleolar proteins change their localizations in response to numerous cellular stresses (Chang et al. 1999; Blander et al. 2002; Gao et al. 2003; Rubbi & Milner 2003; Al-Baker et al. 2004). Under stress conditions, the nucleolus is disrupted and ARF is released inhibiting HDM2 which is a negative regulator of p53 for proteasome-dependent degradation (Olson 2004). In addition, the nucleolar proteins, nucleophosmin/B23 and nucleolin/C23, are also distributed to the nucleoplasm from the nucleolus under many sorts of stresses (Daniely et al. 2002; Kurki et al. 2004b). In response to stresses, nucleophosmin/B23 acts as the negative regulator of the p53-HDM2 complex (Kurki et al. 2004b) and nucleolin/C23 is associated with p53 for replication inhibition and DNA repair (Daniely et al. 2002).
The nucleolus has a wide range of functional categories inferred from the fact that nucleolar proteins possess a diversity of kinetics as well as a transient structure for the production of rRNA synthesis (Kurki et al. 2004a). In the present study, we report a novel nucleolar protein which has a role in the maintenance of ribosomal structure and the damage-response activity.
| Results |
|---|
|
|
|---|
In the previous study, we performed a large-scale genome-wide association analysis to screen specific markers in colon cancer and found significant single nucleotide polymorphisms in c14orf120 gene region at chromosome 14q11.2 (data not shown). The sequence of c14orf120 cDNA was already registered in NCBI (GENBANK accession no. BC030817 [GenBank] ) and classified as a full-length cDNA encoding 315 aa (Strausberg et al. 2002). By in silico analysis, we found that the c14orf120 gene has a conserved protein sequence among species (Fig. 1A) and showed 88.9% and 86.1% homology with Mus musculus in amino acid and DNA sequence respectively. In addition, the c14orf120 protein contains the putative Sas10/Utp3 domain at the N-terminus region (9–107 aa) (Fig. 1B). Although the function of this domain is still unknown, yeast Sas10/Utp protein having a Sas10/Utp3 domain is known as a regulator of chromatin silencing (Kamakaka & Rine 1998) and a component of U3 ribonucleoprotein complex involved in 18S ribosomal RNA biogenesis (Dragon et al. 2002). In the present study, we found that the c14orf120 gene was localized in the centromere in response to DNA damage, so we propose this gene to be called as centromere accumulated nuclear protein 1 (CANu1) in this study.
|
We performed PCR with the multiple tissue cDNA assay to investigate the expression pattern of CANu1 in normal human tissues. CANu1 mRNA was expressed in liver, placenta and pancreas (Fig. 2A). By northern blot analysis, CANu1 mRNA was expressed strongly in Gli3 cells, whereas Hep1 hepatoma cells had a very weak signal (Fig. 2B). In addition, CANu1 mRNA showed only a band at 1.2 kb without alternative splicing (Fig. 2B). To observe the localization of CANu1 in human skin tissue, we performed immunohistochemical assay. As shown in Fig. 2C, the signal of CANu1 localized densely as spots within nucleus. This pattern is very similar to nucleoli staining.
|
The cellular localization of a certain protein could provide useful information for deducing protein function (Hoja et al. 2000). We observed the intracellular localization pattern of CANu1 protein in cells with the plasmid encoding a fusion GFP-CANu1 protein. As shown in Fig. 3A, GFP-CANu1 protein was localized in nucleolus. Nucleolin/C23 protein was used as a nucleolar marker. This result consists with other studies reporting that c14orf120 belongs to nucleoli protein by proteomic analysis (Andersen et al. 2005; Hinsby et al. 2006). These results indicate that CANu1 is a nucleolar protein and GFP-CANu1 fusion protein shows similar pattern to endogenous protein.
|
C) including a Sas10/Utp3 motif was also localized to the nucleolus. However, Sas10/Utp3 domain-deleted mutant (CANu1
N) was continuously kept in the nucleolus, whereas CANu1
C mutant having only the Sas10/Utp3 domain was not localized in the nucleus (Fig. 3B). The C-terminus of CANu1 has many lysine and arginine residues, so this region may have putative NLS motif. These results suggest that the nucleolar localization signal could be embedded in the C-terminus of CANu1 protein outside the Sas10/Utp3 domain. Ribosomal stress by the knock-down of CANu1 gene
A large portion of nucleolar proteins was identified by proteomic techniques, of which approximately 30% were uncharacterized. Andersen et al. (2005) assigned the uncharacterized nucleolar proteins to functional protein complexes of the human nucleolome based on the data from mRNA co-expression, protein interaction reproducibility, and nucleolus protein dynamics. Interestingly, we could find a CANu1 protein in the list of the ribosome biogenesis (mostly pre-40S) complex in the database, suggesting that it may be involved in exporting pre-40S ribosome. Generally, the impaired nucleolar proteins involved in ribosome biogenesis induce ribosomal stress leading to cell death by p53 activation (Pestov et al. 2001; Choesmel et al. 2007). We wonder whether the knock-down of CANu1 causes ribosomal stress to cells, as it is sorted in pre-40S ribosome complex. As a result, the knock-down of CANu1 gene expression by siRNA induced the G1 cell cycle arrest and the elevated level of both p53 and p21 protein expression (Fig. 4A,B). In addition, we tested the localization of B23 in CANu1-depleted cells, because the translocation of B23 protein has been known as a ribosomal stress marker in damaged cells. Interestingly, nucleolar GFP-fused B23 proteins had reduced nucleolar localization and showed shrinkage nucleolar morphology in cells transfected with CANu1 siRNAs (Fig. 4C). These results suggest that the knock-down of CANu1 gene expression leads to ribosomal stress in cells.
|
Since many nucleolar proteins have been known to alter their subcellular localization by cellular stress (Chang et al. 1999; Blander et al. 2002; Gao et al. 2003; Rubbi & Milner, 2003; Al-Baker et al. 2004), we determined whether CANu1 protein could be redistributed in DNA damaged cells. U2OS cells expressing the GFP-CANu1 protein were irradiated by UV (40 J/m2) and then observed. As shown in Fig. 5A, the GFP-CANu1 protein was translocated from nucleolus to nucleoplasm and formed nuclear foci in cells exposed to UV. The translocation pattern of the GFP-CANu1 protein is reminiscent of the damage-induced translocation of WRN protein (Blander et al. 2002). However, cells expressing the GFP-CANu1
N protein, Sas10/Utp3 domain deleted mutant, did not form nuclear foci under UV irradiation (data not shown). These results support that the formation of nuclear foci is Sas10/Utp3 domain-dependent.
|
and HP1β-DsRed proteins (Fig. 5B). In addition, the localization of GFP-CANu1 foci was consistent with CREST antisera, a marker for centromeres (Fig. 5C). These results suggest that the GFP-CANu1 protein may associate with pericentromeric regions in cells in response to UV damage. In order to define the upstream pathway for the translocation of CANu1 protein, we tested several known pathways involved in the induction of nucleolar protein dispersion. In our results, the translocation of CANu1 was independent for JNK2, ATM/ATR and Chk2 pathways (Fig. 6). CANu1 may have alternative pathway to be nucleoplasmic distribution in cells in response to UV.
|
We next analyzed the relevance of CANu1 mobility in the formation of the damage-induced foci in living cells. The FRAP assay was performed with the GFP-CANu1 plasmids. The mobility of GFP-CANu1 in UV-damaged cells was enhanced by 2-times compared to that of control cells (Fig. 7A,B). In contrast, the mobility of GFP-CANu1
N protein did not changed under UV damage (data not shown). Taken together, the mobility of CANu1 protein in U2OS cells was enhanced by UV damage and the Sas10/Utp3 domain of CANu1 was required for both the formation of nuclei foci and protein mobility under UV stress.
|
| Discussion |
|---|
|
|
|---|
Centromeres are made up histone proteins and other component proteins. Centromeric heterochromatin lies on the flank region of centromeres termed the pericentromeric region and is essential for centromere formation (Amor et al. 2004). The exposure of human cells to DNA-damaging agents induces pairing of the homologous paracentromeric heterochromatin dependent on DNA repair (Abdel-Halim et al. 2005, 2006). The heterochromatin protein 1 (HP1) family is localized at centromeric heterochromatin to maintain its structure (Sugimoto et al. 2001; Hayakawa et al. 2003; Maison & Almouzni 2004). HP1 family belongs to non-histone proteins consisting of three type forms, HP1
, HP1β and HP1
in human (Maison & Almouzni 2004). In our study, the foci-induced by GFP-CANu1 protein was partially co-localized with the HP1
and HP1β-DsRed proteins. HP1
and HP1
are primarily localized at PML nuclear bodies and HP1β is mainly localized at centromeres during interphase (Hayakawa et al. 2003). These results suggest that the GFP-CANu1 protein may associate with the pairing of the homologous paracentromeric heterochromatin dependent on DNA repair.
We also demonstrated that the Sas10/Utp3 domain of CANu1 is essential for the formation of nuclear foci and the alteration of mobility. In yeast, Sas10/Utp3 protein was localized in the nucleolus (Dragon et al. 2002) and induced the derepression of HMR and HML genes when over-expressed (Kamakaka & Rine 1998). In contrast, when Sas10/Utp3 gene is repressed, cells are arrested at late S or G2/M phases with the abnormal nuclear morphology (Kamakaka & Rine 1998). Based on these results, yeast Sas10/Utp3 protein regulates the acetylation state at silenced region or the higher-order chromatin structure to regulate on–off state of gene (Kamakaka & Rine 1998). Therefore, CANu1 performs as a higher-order chromatin structure regulator by accumulating at centromeric heterochromatin using Sas10/Utp3 domain under stress.
In conclusion, our studies provide several evidences that CANu1 protein is a novel nucleolar protein to be accumulated at nuclear foci upon damages.
| Experimental procedures |
|---|
|
|
|---|
Human osteosarcoma U2OS cells were cultured in Dulbecco's modified medium supplemented with 10% fetal bovine serum, and incubated in a humidified incubator at 37 °C with 5% CO2. U2OS cells were grown on 35 mm dishes with coverslip and were transfected by using ExGen500 reagent (MBI Fermentas, Hanover, MD) by following the manufacturer's instructions. At 24 h post-transfection, cells were irradiated with UVC (ULTRA-LUM; 254 nm, 40 J/m2). To block ATM/ATR and JNK2 pathway, cells were treated with caffeine (2 mM for 1 h) and SP600125 (5 µM for 30 min) respectively in prior to the treatment of the stress. To suppress the mRNA level of the CANu1, we obtained short-interfering RNA (siRNA) against CANu1 (target sequence: TCCCAGCAATATGATGAGCAA) and scrambled siRNA (cat. no.: 1027281) from Qiagen (Santa Clarita, CA). At 24 h after plating the cells were transfected by Oligofectin transfection reagent (Invitrogen Life Technologies, Carlsbad, CA), following the manufacturer's instructions.
Cloning of CANu1 cDNA
To obtain the full length of human CANu1 cDNA, total RNA was isolated with Trizol reagent (Invitrogen Life Technologies). Total RNA was reacted with oligo(dT) primer and MMLV reverse transcriptase (TaKaRa, Bio Inc., Shiga, Japan) at 42 °C for 60 min. To generate EGFP-CANu1, EGFP-CANu1
N, GFP-B23, B23-DsRed, HP1
-DsRed and HP1β-DsRed constructs, cDNAs were amplified by PCR using the CANu1 (forward: 5'-atggcg gcgctgggggtg-3' and reverse: 5'-tcaccgccgcctccgaaa-3'), B23 (forward: 5'-atggaagattcgatggac-3' and reverse: 5'-aagagacttcctccactg-3'), HP1
(forward: 5'-atgggaaagaaaaccaagcg-3' and reward: 5'-ttagctcttt gctgtttctt-3') and HP1β (forward: 5'-atggggaaaaaacaaaacaag-3' and reward: 5'-ttagttcttgtcatctttttt-3') primers and then were TA-cloned (Promega, Madison, WI). After amplification by using specific primers to generate enzyme sites, PCR products were digested by appropriate enzymes. Digested products were cloned into pEGFPC1 (BD Biosciences, Palo Alto, CA) or pDsRed2N1 plasmids (BD Biosciences). All clones were confirmed by DNA sequencing.
Immunofluorescence microscopy
U2OS cells expressing GFP-CANu1 fusion protein or HP1-DsRed constructs were cultured on coverslips for 24 h and were irradiated by UV (40 J/m2). Six hours later, cells were fixed with 4% paraformaldehyde for 15 min and washed three times with PBS. After blocking with 10% horse serum, coverslips were incubated with primary antibodies at a 1 : 250 dilution (
-CREST and
-
H2AX) in a humidified chamber for 1 h. After washing with PBS containing 0.1% NP-40, samples were incubated with secondary antibodies conjugated to Cy-3 or TRITC (Sigma-Aldrich, Saint Louis, MO) at a dilution of 1 : 100 in PBS (0.1% NP-40) for 45 min. Cells were stained by DAPI (0.1 µg/mL) for 5 min to detect nuclei. We used a nucleolin/C23 primary antibody (1 : 20 dilution, Santa Cruz Biotechnology, Santa Cruz, CA) with TRITC-conjugated secondary antibody (1 : 150 dilution) to stain nucleoli. Samples were mounted and visualized using a LSM 510 microscope (Carl Zeiss, Oberkochen, Germany).
Northern blot and multiple tissue cDNA assay
Total RNA was isolated from several cell lines with the Trizol (Invitrogen Life Technologies) by following the manufacturer's instructions. For northern blot analysis, 10 µg of RNA was separated in 1% formaldehyde-agarose gels. Gels were transferred to nylon membranes and the RNA was fixed by UV-cross-linking. Membranes were prehybridized at 65 °C for 1 h in ExpressHyb buffer (BD Biosciences). cDNA probes for CANu1 full-length (948 bp) and β-actin were labeled by a random priming kit (Roche, Meylan, France) using [32P]-dCTP (3000 Ci/mmol) and Klenow DNA polymerase (Roche). Probes were purified, diluted in Rapid-Hyb buffer (BD Biosciences), and incubated with membranes for 3 h at 65 °C. After hybridization, membranes were washed with a buffer (1x SSC and 1% SDS). Membranes were exposed and developed using a Molecular Imager FX imaging system (Bio-Rad, Hercules, CA). To analyze the expression pattern of CANu1 in tissues, the human multiple tissue cDNA panel (BD Biosciences) was used. Human cDNAs were amplified by PCR using the CANu1 (forward: 5'-atggcggcgctgggggtg-3' and reverse: t caccgccgcctccgaaa-3') and GAPDH (forward: 5'-catcac catcttccaggagc-3', reverse: 5'-ccacctggtgctcagtgtag-3') primers. Amplification was carried out for 30 cycles. Cycling conditions were as follow: denaturation at 95 °C for 1 min, annealing at 60 °C for 1 min and extension at 72 °C for 1 min. PCR products were visualized in 1% agarose gels stained with ethidium bromide.
Cell cycle analysis
Cells were incubated with siRNA (50 nM) for 72 h. Cells were fixed in ethanol, washed with PBS, and resuspended in PI staining buffer (100 µg/mL PI and 1 mg/mL RNAse). DNA content was evaluated by flow cytometry (Cytomics FC 500, Becton Dickinson, Miami, FL).
FRAP analysis
FRAP analysis was performed with a Zeiss LSM 510 inverted confocal laser scanning microscope equipped with an on-stage heating chamber. We determined the region of interest (ROI) from cells expressing GFP fused proteins. ROI was bleached with maximum laser power (488-nm, 6.5 mW) for 15 iterations. Subsequently, the recovery of fluorescence in the ROI was monitored at intervals of 500 ms with the same laser at 3% of the power applied for bleaching using a dichroic beam splitter (488/543 nm) and an additional 515–540 nm band pass filter for emission detection. Bleaching occurred after 5 pre-bleach images.
Antibody production
A glutathione S-transferase (GST)-tagged full-length CANu1 fusion protein was amplified in transformant bacteria (BL21) and purified using Glutathione Sepharose 4B (Peptron, Daejon, Korea). Purified GST-CANu1 proteins were injected into New Zealand White rabbits. Polyclonal antibodies obtained from the immunized rabbits were purified by affinity-purification with His6-CANu1 immobilized on nitrocellulose membrane.
Cell fraction and immunoblotting
U2OS cells were treated with siRNA (50 nM for 72 h) by Oligofectamin reagent (Invitrogen Life Technologies) and were lysed into NP-40 lysis buffer [50 mM Tris–HCl, 150 mM NaCl, 1% NP-40, 50 mM NaF, 200 µM Na3VO4, protease inhibitor cocktail tablets (Roche) and 0.1% SDS]. The concentrations of separated protein were determined by a Bio-Rad protein assay (Bio-Rad) and were normalized for SDS-PAGE analysis. Protein extracts were resolved by electrophoresis on SDS polyacrylamide gels. After electrophoretic transfer to nitrocellulose, reactive proteins were detected using antibodies specific against CANu1 (1 : 100 dilution), p53 (1 : 1000 dilution, Santa Cruz Biotechnology, sc-126) and p21 (1 : 500 dilution, Upstate, 05-345) with the ECL kit (Santa Cruz Biotechnology).
Immunohistochemistry
Resected skin tissue was processed through formalin-fixation and paraffin-embedding. The immunostaining was performed with DAKO EnVision Kit (DakoCytomation, Glostrup, Denmark). Briefly, tissue sections in 4 µm in thickness were dewaxed and rehydrated at graded alcohols. Endogenous peroxidase was blocked by dipping sections in 3% aqueous hydrogen peroxide for 10 min. Antigen retrieval was added for 10 min in microwave by treatment of 10 mmol/L citrate buffer, pH 6.0. Primary antibody for a mouse homolog of CANu1 NGDN (1 : 100 in dilution; Atlas Antibodies, Cleveland, OH) was treated for 1 h at room temperature. Next, the sections were incubated with EnVisionTM reagent (DakoCytomation), which is a peroxidase-conjugated polymer backbone, carrying secondary antibody molecules. The sections were lightly counterstained with hematoxylin. NGDN localized in nucleoli of epidermal keratinocytes.
| Acknowledgements |
|---|
| Footnotes |
|---|
aPresent address: Research Institute, National Cancer Center, Gyeonggi-do Goyang-si 410-769, Republic of Korea.
| References |
|---|
|
|
|---|
Abdel-Halim, H.I., Natarajan, A.T., Mullenders, L.H. & Boei, J.J. (2005) Mitomycin C-induced pairing of heterochromatin reflects initiation of DNA repair and chromatid exchange formation. J. Cell Sci. 118, 1757–1767.
Al-Baker, E.A., Boyle, J., Harry, R. & Kill, I.R. (2004) A p53-independent pathway regulates nucleolar segregation and antigen translocation in response to DNA damage induced by UV irradiation. Exp. Cell Res. 292, 179–186.[CrossRef][Medline]
Amor, D.J., Kalitsis, P., Sumer, H. & Choo, K.H. (2004) Building the centromere: from foundation proteins to 3D organization. Trends Cell Biol. 14, 359–368.[CrossRef][Medline]
Andersen, J.S., Lam, Y.W., Leung, A.K., Ong, S.E., Lyon, C.E., Lamond, A.I. & Mann, M. (2005) Nucleolar proteome dynamics. Nature 433, 77–83.[CrossRef][Medline]
Blander, G., Zalle, N., Daniely, Y., Taplick, J., Gray, M.D. & Oren, M. (2002) DNA damage-induced translocation of the Werner helicase is regulated by acetylation. J. Biol. Chem. 277, 50934–50940.
Carmo-Fonseca, M., Mendes-Soares, L. & Campos, I. (2000) To be or not to be in the nucleolus. Nat. Cell Biol. 2, E107–112.[CrossRef][Medline]
Chang, M.S., Sasaki, H., Campbell, M.S., Kraeft, S.K., Sutherland, R., Yang, C.Y., Liu, Y., Auclair, D., Hao, L., Sonoda, H., Ferland, L.H. & Chen, L.B. (1999) HRad17 colocalizes with NHP2L1 in the nucleolus and redistributes after UV irradiation. J. Biol. Chem. 274, 36544–36549.
Choesmel, V., Bacqueville, D., Rouquette, J., Noaillac-Depeyre, J., Fribourg, S., Crétien, A., Leblanc, T., Tchernia, G., Da Costa, L. & Gleizes, P.E. (2007) Impaired ribosome biogenesis in Diamond-Blackfan anemia. Blood 109, 1275–1283.
Daniely, Y., Dimitrova, D.D. & Borowiec, J.A. (2002) Stress-dependent nucleolin mobilization mediated by p53-nucleolin complex formation. Mol. Cell Biol. 22, 6014–6022.
Dragon, F., Gallagher, J.E., Compagnone-Post, P.A., Mitchell, B.M., Porwancher, K.A., Wehner, K.A., Wormsley, S., Settlage, R.E., Shabanowitz, J., Osheim, Y., Beyer, A.L., Hunt, D.F. & Baserga, S.J. (2002) A large nucleolar U3 ribonucleoprotein required for 18S ribosomal RNA biogenesis. Nature 417, 967–970.[CrossRef][Medline]
Gao, H., Chen, X.B. & McGowan, C.H. (2003) Mus81 endonuclease localizes to nucleoli and to regions of DNA damage in human S-phase cells. Mol. Biol. Cell 14, 4826–4834.
Hayakawa, T., Haraguchi, T., Masumoto, H. & Hiraoka, Y. (2003) Cell cycle behavior of human HP1 subtypes: distinct molecular domains of HP1 are required for their centromeric localization during interphase and metaphase. J. Cell Sci. 116, 3327–3338.
Hinsby, A.M., Kiemer L., Kaarlberg E.O., Lage K., Fausboll, A., Juncker A.S., Andersen J.S., Mann, M. & Brunak, S. (2006) A wiring of the human nucleolus. Mol. Cell 22, 285–295.[CrossRef][Medline]
Hoja, M.R., Wahlestedt, C. & Höög, C. (2000) A visual intracellular classification strategy for uncharacterized human proteins. Exp. Cell Res. 259, 239–246.[CrossRef][Medline]
Jung, M.Y., Lorenz, L. & Richter, J.D. (2006) Translational control by neuroguidin, a eukaryotic initiation factor 4E and CPEB binding protein. Mol. Cell Biol. 26, 4277–4287.
Kamakaka, R.T. & Rine, J. (1998) Sir- and silencer-independent disruption of silencing in Saccharomyces by Sas10p. Genetics 149, 903–914.
Kurki, S., Peltonen, K. & Laiho, M. (2004a) Nucleophosmin, HDM2 and p53: players in UV damage incited nucleolar stress response. Cell Cycle 3, 976–979.[Medline]
Kurki, S., Peltonen, K., Latonen, L., Kiviharju, T.M., Ojala, P.M., Meek, D. & Laiho M. (2004b) Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 5, 465–475.[CrossRef][Medline]
Lamond, A.I. & Earnshaw, W.C. (1998) Structure and function in the nucleus. Science 280, 547–553.
Leung, A.K., Andersen, J.S., Mann, M. & Lamond, A.I. (2003) Bioinformatic analysis of the nucleolus. Biochem. J. 376, 553–569.[CrossRef][Medline]
Maison, C. & Almouzni, G. (2004) HP1 and the dynamics of heterochromatin maintenance. Nat. Rev. Mol. Cell Biol. 5, 296–304.[CrossRef][Medline]
Mayer, C. & Grummt, I. (2005) Cellular stress and nucleolar function. Cell Cycle 4, 1036–1038.[Medline]
Olson, M.O. (2004) Sensing cellular stress: another new function for the nucleolus? Sci. STKE. 224, 10–11.
Olson, M.O., Dundr, M. & Szebeni, A. (2000) The nucleolus: an old factory with unexpected capabilities. Trends Cell Biol. 10, 189–196.[CrossRef][Medline]
Pestov, D.G., Strezoska, Z. & Lau, L.F. (2001) Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Mol. Cell Biol. 21, 4246–4255.
Rubbi, C.P. & Milner, J. (2003) Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO. J. 22, 6068–6077.[CrossRef][Medline]
Scherl, A., Couté, Y., Déon, C., Callé, A., Kindbeiter, K., Sanchez, J.C., Greco, A., Hochstrasser, D. & Diaz, J.J. (2002) Functional proteomic analysis of human nucleolus. Mol. Biol. Cell 13, 4100–4109.
Strausberg, R.L., Feingold, E.A., Grouse, L.H. et al.; Mammalian Gene Collection Program Team. (2002) Generation and initial analysis of more than 15 000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. USA 99, 16899–16903.
Sugimoto, K., Tasaka, H. & Dotsu, D. (2001) Molecular behavior in living mitotic cells of human centromere heterochromatin protein HPL
ectopically expressed as a fusion to red fluorescent protein. Cell Struct. Funct. 26, 705–718.[CrossRef][Medline]
Accepted: 23 April 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | ADVANCED SEARCH | TABLE OF CONTENTS |